Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Retrospective single-centre assessment of theoretical eligibility and drug-drug interactions; descriptive analysis without a comparator, control group, or clinical outcome measurement.
Single-centre cross-sectional study of prevalence and associated factors in a specific population; provides descriptive findings without a control group or intervention, suitable for hypothesis generation and local planning but requiring confirmation in broader populations.
A systematic review synthesizing epidemiological evidence and clinical knowledge on HPV and cervical cancer to inform prevention strategy and public health policy, structured by PRISMA guidelines.
Mathematical modeling study using indirect calibration to surveillance data; produces state-level estimates but lacks direct validation and relies on assumptions about undiagnosed infections.
Single-centre pilot feasibility study with uncontrolled design and surrogate endpoints (molecular detection); demonstrates technical capability and epidemiological associations but lacks comparative evidence or clinical outcome data needed to guide practice.
This is a literature review and descriptive analysis of cervical cancer challenges in one country, without original empirical data, control groups, or quantified treatment outcomes.
Large propensity-matched observational cohort study with clear associations between DMTs and multiple gynecologic complications, reported with effect sizes and confidence intervals, but causal inference is limited by observational design.
Single-arm algorithm development study on a public dataset with surrogate imaging endpoints (segmentation accuracy metrics) and no clinical validation or prospective comparison.